FBVision

FB Vision is an ophthalmic company founded in 2015 as part of the FB international scientific research group, focused on researching, developing and manufacturing high-quality products for preventing and treating eye pathologies, with main therapeutic areas including dry eye, glaucoma, neuroprotection and ocular surgery. Named for founder Francesco Bellini, an Italian-Canadian scientist-entrepreneur in the Canadian biopharmaceutical industry, FB Vision brings together a team with strong ophthalmic industry experience, aiming to become a reference point for ophthalmologists and patients.